Granular Therapeutics Ltd Company Profile, Contacts & Intelligence

Granular Therapeutics Ltd Overview

In many chronic inflammatory diseases, mast cells are central drivers of pathology. The paucity of mast cell-selective drugs leaves a huge unmet medical need in this area. Targeting of mast cells via indiscriminate blocking of c-KIT signalling, while potentially efficacious, can lead to severe, dose-limiting bone marrow suppression. Granular’s approach targets mast cells specifically & powerfully, for top-down, disease-modifying immune modulation with improved safety profile.

Headquarters

Innovation House, United Kingdom

Website

www.granulartherapeutics.com

Industry

Biotechnology Research

Founded

2017

NAICS

Research and Development in Biotechnology (except Nanobiotechnology)

Granular Therapeutics Ltd Contact Intelligence

See which contact channels and departments are represented in the visible AeroLeads data.

Granular Therapeutics Ltd People & Org Chart Preview

Sample people records show job titles and whether email or phone data is available without exposing raw contact details.

Compare Similar Companies to Granular Therapeutics Ltd

Explore companies in related markets and compare their industry and employee estimates.